Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. The two doses of NUVIGIL produced statistically significant effects of similar magnitudes on the MWT, and also on the CGI-C. Use Caution/Monitor. armodafinil and caffeine both decrease sedation. Consider dose reduction of sensitive CYP3A4 substrates. armodafinil will decrease the level or effect of duloxetine by affecting hepatic enzyme CYP1A2 metabolism. Monitor Closely (1)armodafinil will decrease the level or effect of erlotinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Effect of interaction is not clear, use caution. ethanol increases and armodafinil decreases sedation. Minor (1)armodafinil will increase the level or effect of ruxolitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (3)armodafinil will decrease the level or effect of iloperidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (2)armodafinil will decrease the level or effect of cilostazol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Effect of interaction is not clear, use caution. If coadministration is unavoidable, monitor patients for loss of therapeutic effect of these drugs. armodafinil will decrease the level or effect of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Serious - Use Alternative (1)armodafinil will decrease the level or effect of ethinylestradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. How Does Nuvigil Work? Serious - Use Alternative (1)armodafinil will decrease the level or effect of rimegepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Manage and view all your plans together even plans in different states. Share cases and questions with Physicians on Medscape consult. Serious - Use Alternative (1)idelalisib will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. miconazole vaginal will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. butabarbital increases and armodafinil decreases sedation. verapamil will increase the level or effect of armodafinil by P-glycoprotein (MDR1) efflux transporter. Effect of interaction is not clear, use caution. Lomitapide dose should not exceed 30 mg/day. Contraindicated. prednisone will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Effect of interaction is not clear, use caution. Minor (1)yerba mate increases effects of armodafinil by pharmacodynamic synergism. armodafinil increases toxicity of cilostazol by affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely. Effect of interaction is not clear, use caution. Use Caution/Monitor. A study by M. Darwish and colleagues published in 2009 in Clinical Drug Investigation found that Nuvigil blood concentrations were higher than Provigil late in the day. Avoid or Use Alternate Drug. Use Caution/Monitor. In patients with severe hepatic impairment, the dosage of NUVIGIL should be reduced [see Use in Specific Populations (8.6) and Clinical Pharmacology (12.3)]. Strong or moderate CYP2C19 inhibitors may increase mavacamten systemic exposure, resulting in heart failure due to systolic dysfunction. armodafinil will decrease the level or effect of macimorelin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If any of these effects last or get worse, tell your doctor or pharmacist promptly. Avoid coadministration of lefamulin with strong or moderate CYP3A inducers unless the benefit outweighs risks. armodafinil will decrease the level or effect of cyclosporine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If you become pregnant, talk to your doctor right away about the risks and benefits of this medication.It is unknown if this drug passes into breast milk. armodafinil will decrease the level or effect of vonoprazan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. armodafinil will decrease the level or effect of neratinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Serious - Use Alternative (1)armodafinil will decrease the level or effect of lovastatin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. armodafinil will decrease the level or effect of avapritinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Monitor Closely (1)armodafinil will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. armodafinil will decrease the level or effect of disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)rasagiline increases effects of armodafinil by pharmacodynamic synergism. Use Caution/Monitor. Minor/Significance Unknown. Avoid or Use Alternate Drug. Use Caution/Monitor. Serious - Use Alternative (1)armodafinil decreases levels of axitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Effect of interaction is not clear, use caution. Use Caution/Monitor. Minor (1)clotrimazole will decrease the level or effect of armodafinil by P-glycoprotein (MDR1) efflux transporter. armodafinil will decrease the level or effect of pemigatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. It is thought to work by affecting certain substances in the brain that control the sleep/wake cycle. Serious - Use Alternative (1)armodafinil will decrease the level or effect of lemborexant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. PRECAUTIONS: Before taking armodafinil, tell your doctor or pharmacist if you are allergic to it; or to modafinil; or if you have any other allergies. Effect of interaction is not clear, use caution. This effect was not observed with istradefylline 20 mg/day. esketamine intranasal, armodafinil. armodafinil will decrease the level or effect of tacrolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)armodafinil will decrease the level or effect of lopinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. The authors said it . dextromoramide increases and armodafinil decreases sedation. Avoid or Use Alternate Drug. Use Caution/Monitor. Use Caution/Monitor.Minor (1)nicardipine will increase the level or effect of armodafinil by P-glycoprotein (MDR1) efflux transporter. Effect of interaction is not clear, use caution. Use Caution/Monitor. Monitor Closely (1)levoketoconazole will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. armodafinil will decrease the level or effect of temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Minor/Significance Unknown. Avoid or Use Alternate Drug. Strong or moderate CYP2C19 inhibitors may decrease rate of diazepam elimination, thereby increasing adverse reactions to diazepam. Use Caution/Monitor. Effect of interaction is not clear, use caution. Use Caution/Monitor. armodafinil will decrease the level or effect of erythromycin base by affecting hepatic/intestinal enzyme CYP3A4 metabolism. guarana increases effects of armodafinil by pharmacodynamic synergism. Avoid coadministration. depression, anxiety, hallucinations, aggression, unusual thoughts or behavior, suicidal thoughts. armodafinil and methamphetamine both decrease sedation. Use Caution/Monitor. armodafinil will decrease the level or effect of propafenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Serious - Use Alternative (1)armodafinil will decrease the level or effect of iobenguane I 131 by Other (see comment). Both drugs act as eugeroics and are considered "wakefulness-promoting agents" in that they are distinct from more potent, habit-forming psychostimulants (e.g. Use Caution/Monitor. Lonafarnib is a sensitive CYP3A4 substrate. armodafinil will decrease the level or effect of sufentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Minor (1)quinupristin/dalfopristin will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. The therapeutic effect of elbasvir/grazoprevir may be reduced if coadministered with moderate CYP3A inducers and should be avoided. Monitor Closely (1)cenobamate will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Use Caution/Monitor. Last updated on Dec 31, 2022. armodafinil will decrease the level or effect of zaleplon by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor for hypertension with concomitant use. armodafinil will decrease the level or effect of lefamulin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Based on the mechanism of action of iobenguane, drugs that reduce catecholamine uptake or that deplete catecholamine stores may interfere with iobenguane uptake into cells, and thus, reduce iobenguane efficacy. Avoid use of lorlatinib with moderate CYP3A inducers. Strong or moderate CYP3A inducers may decrease cobimetinib systemic exposure by >80% and reduce its efficacy. The recommended dosage of Viagra for erectile dysfunction (ED) is 50 mg, taken as needed about 1 hour before sexual activity. Effect of interaction is not clear, use caution. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely. Modify Therapy/Monitor Closely. Dosing & Uses AdultPediatricGeriatric Dosage Forms & Strengths tablet: Schedule IV 50mg 150mg 200mg 250mg Obstructive Sleep Apnea Indicated to improve wakefulness in adults with excessive. Use Caution/Monitor. armodafinil will decrease the level or effect of diltiazem by affecting hepatic/intestinal enzyme CYP3A4 metabolism. #354-73, #378-79) began appearing in August 1934, continuing through June 1936.. Minor (1)zafirlukast will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Effect of interaction is not clear, use caution. Use Caution/Monitor. armodafinil will decrease the level or effect of caffeine by affecting hepatic enzyme CYP1A2 metabolism. Avoid or Use Alternate Drug. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Minor/Significance Unknown. Dose adjustment is recommended with concomitant use of ubrogepant and moderate and weak CYP3A4 inducers. Minor/Significance Unknown. Monitor Closely (1)armodafinil will decrease the level or effect of cyclosporine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)armodafinil will decrease the level or effect of levamlodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. When a moderate inducer discontinued, continue erdafitinib at same dose, in absence of drug-related toxicity. Monitor Closely (1)cimetidine will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. amitriptyline increases and armodafinil decreases sedation. Monitor Closely (1)armodafinil will decrease the level or effect of tivozanib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. armodafinil will increase the level or effect of clobazam by affecting hepatic enzyme CYP2C19 metabolism. acetazolamide will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. armodafinil will decrease the level or effect of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (2)armodafinil will decrease the level or effect of olanzapine by affecting hepatic enzyme CYP1A2 metabolism. Avoid coadministration with moderate or strong CYP3A4 inducers. armodafinil will decrease the level or effect of venetoclax by affecting hepatic/intestinal enzyme CYP3A4 metabolism. oxcarbazepine will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Chemical Name: armodafinil Usage in MS: Fatigue Generic Available: No Description Armodafinil is used to improve wakefulness in adults who experience excessive sleepiness due to obstructive sleep apnea, shift work disorder or narcolepsy. armodafinil will decrease the level or effect of ergotamine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Use Caution/Monitor. armodafinil and xylometazoline both decrease sedation. Use Caution/Monitor. rifapentine will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Voxelotor is primarily metabolized by CYP3A4. Avoid or Use Alternate Drug.Minor (1)erythromycin ethylsuccinate will increase the level or effect of armodafinil by P-glycoprotein (MDR1) efflux transporter. Minor (1)quercetin will decrease the level or effect of armodafinil by P-glycoprotein (MDR1) efflux transporter. Potential for additive CNS stimulation. DOSAGE & INDICATIONS. Effect of interaction is not clear, use caution. Use Caution/Monitor.Minor (1)methylprednisolone will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)trifluoperazine increases and armodafinil decreases sedation. quetiapine increases and armodafinil decreases sedation. armodafinil will decrease the level or effect of tizanidine by affecting hepatic enzyme CYP1A2 metabolism. Effect of interaction is not clear, use caution. Avoid or Use Alternate Drug. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. armodafinil will decrease the level or effect of cevimeline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Risk of acute hypertensive episode. Use Caution/Monitor.Minor (1)aprepitant will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)armodafinil and modafinil both decrease sedation. Tablet 50mg; Tablet 150mg; Tablet 200mg; Tablet 250mg; Common Nuvigil Prescriptions. Monitor Closely (1)ketotifen, ophthalmic increases and armodafinil decreases sedation. Monitor Closely (1)chloral hydrate increases and armodafinil decreases sedation. Closely monitor blood pressure with concomitant use of esketamine nasal with stimulants. Use Caution/Monitor. Use Caution/Monitor.Minor (1)armodafinil will decrease the level or effect of sufentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Effect of interaction is not clear, use caution. armodafinil will decrease the level or effect of erdafitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)armodafinil will decrease the level or effect of docetaxel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)armodafinil will decrease the level or effect of nicardipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Your doctor may adjust your dose if needed. Avoid or Use Alternate Drug. Use Caution/Monitor.Minor (1)fludrocortisone will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Minor/Significance Unknown.clarithromycin will increase the level or effect of armodafinil by P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.Minor (1)fosamprenavir will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely. Velpatasvir inhibits CYP3A4. Use Caution/Monitor. armodafinil will decrease the level or effect of colchicine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Back-up contraception should be continued for 28 days after discontinuing medication to ensure contraceptive reliability. Risk of acute hypertensive episode. doxepin increases and armodafinil decreases sedation. Minor/Significance Unknown. lumefantrine will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Use Caution/Monitor.Minor (1)marijuana will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Information last revised January 2023. Minor/Significance Unknown. Monitor Closely (2)armodafinil will increase the level or effect of amitriptyline by affecting hepatic enzyme CYP2C19 metabolism. Effect of interaction is not clear, use caution. Avoid or Use Alternate Drug. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Serious - Use Alternative (1)armodafinil will decrease the level or effect of leniolisib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Use Caution/Monitor. armodafinil will decrease the level or effect of fesoterodine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. armodafinil and phendimetrazine both decrease sedation. Adjust dose of drugs that are CYP3A4 substrates as necessary. Use Caution/Monitor. Effect of interaction is not clear, use caution. If you notice other effects not listed above, contact your doctor or pharmacist.In the US -Call your doctor for medical advice about side effects. Avoid or substitute another drug for these medications when possible. armodafinil will decrease the level or effect of tolterodine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)fluphenazine increases and armodafinil decreases sedation. Use Caution/Monitor. Monitor Closely (1)armodafinil will decrease the level or effect of ubrogepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.Minor (1)prednisone will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. armodafinil increases effects of ifosfamide by affecting hepatic enzyme CYP2B6 metabolism. Minor/Significance Unknown. Minor (1)griseofulvin will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (2)rifampin will decrease the level or effect of armodafinil by P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown. Use Caution/Monitor. phenytoin will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (3)armodafinil will decrease the level or effect of imipramine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor. armodafinil will increase the level or effect of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Effect of interaction is not clear, use caution. Monitor Closely (1)shepherd's purse increases and armodafinil decreases sedation. Avoid or Use Alternate Drug.Minor (1)erythromycin lactobionate will increase the level or effect of armodafinil by P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor. armodafinil will decrease the level or effect of ritonavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. SIDE EFFECTS: Headache, nausea, dry mouth, nervousness, dizziness, or difficulty sleeping may occur. Use Caution/Monitor. Minor (1)posaconazole will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Minor/Significance Unknown. hydroxyzine increases and armodafinil decreases sedation. Use Caution/Monitor. Avoid coadministration of venetoclax with strong or moderate CYP3A inducers. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown.armodafinil will decrease the level or effect of ondansetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)isoniazid will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Monitor Closely (1)armodafinil will decrease the level or effect of naldemedine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Use Caution/Monitor.armodafinil will decrease the level or effect of etravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Effect of interaction is not clear, use caution. Monitor Closely (1)armodafinil will decrease the level or effect of lidocaine by affecting hepatic enzyme CYP1A2 metabolism. Effect of interaction is not clear, use caution. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. pholcodine increases and armodafinil decreases sedation. Minor (1)armodafinil will decrease the level or effect of eplerenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Encorafenib both inhibits and induces CYP3A4 at clinically relevant plasma concentrations. Nuvigil (armodafinil) is a brand-name drug that's prescribed for improving wakefulness and sleepiness due to narcolepsy, obstructive sleep apnea, or shift work disorder. Coadministration of mild CYP3A4 inhibitors with midazolam intranasal may cause higher midazolam systemic exposure, which may prolong sedation. armodafinil will decrease the level or effect of diazepam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Effect of interaction is not clear, use caution. Minor/Significance Unknown. Use Caution/Monitor.Serious - Use Alternative (1)armodafinil will decrease the level or effect of erythromycin base by affecting hepatic/intestinal enzyme CYP3A4 metabolism. alprazolam increases and armodafinil decreases sedation. Serious - Use Alternative (1)cobicistat will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Minor/Significance Unknown. Minor/Significance Unknown. diphenoxylate hcl increases and armodafinil decreases sedation. Modify Therapy/Monitor Closely. Caution if coadministered with drugs with narrow therapeutics indexes.Serious - Use Alternative (1)armodafinil will decrease the level or effect of sofosbuvir/velpatasvir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Doses of Provigil 800mg per day and above were shown to have higher incidence of side effects with no measurable improvement in symptom relief. Lencapavir (a moderate CYP3A4 inhibitor) may increase CYP3A4 substrates initiated within 9 months after last SC dose of lenacapavir, which may increase potential risk of adverse reactions of CYP3A4 substrates. No information is available on the quantitative effects of CYP3A4 inducers on amlodipine. Avoid or Use Alternate Drug.Minor (1)erythromycin base will increase the level or effect of armodafinil by P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown. Minor/Significance Unknown. Fezolinetant AUC and peak plasma concentration are increased if coadministered with drugs that are weak, moderate, or strong CYP1A2 inhibitors. lenacapavir will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. armodafinil decreases levels of ponatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. armodafinil, epinephrine inhaled. Avoid coadministration of deflazacort with moderate or strong CYP3A4 inducers. Selection of concomitant medication with no or minimal CYP3A4 induction potential is recommended. Monitor Closely (1)dexmedetomidine increases and armodafinil decreases sedation. Serious - Use Alternative (1)armodafinil will decrease the level or effect of cabozantinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)armodafinil will decrease the level or effect of hydroxyprogesterone caproate (DSC) by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Back-up contraception should be continued for 28 days after discontinuing medication to ensure contraceptive reliability. Monitor Closely (1)armodafinil will decrease the level or effect of mestranol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. This drug is available at the lowest co-pay. These new Austria stamps are all typographed and either perforated 12 or perforated 12 1/2. Use Caution/Monitor. armodafinil will decrease the level or effect of carbamazepine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.Minor (1)butabarbital will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Warnings Monitor Closely (1)armodafinil and phenylephrine PO both decrease sedation. Contraindicated. Use Caution/Monitor. isoniazid will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. This could cause pregnancy. Minor/Significance Unknown. Minor/Significance Unknown. Monitor Closely (1)cinnarizine increases and armodafinil decreases sedation. Effect of interaction is not clear, use caution. Monitor Closely (1)meprobamate increases and armodafinil decreases sedation. Minor/Significance Unknown. isocarboxazid increases effects of armodafinil by pharmacodynamic synergism. rufinamide will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Nuvigil (armodafinil) Contents About Generic Side effects Dosage Alternatives FAQs Butabarbital will decrease the level or effect of armodafinil by pharmacodynamic synergism > 80 % and its. Effects dosage Alternatives no information is available on the quantitative effects of armodafinil by affecting hepatic/intestinal enzyme CYP3A4.... 28 days after discontinuing medication to ensure contraceptive reliability of propafenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism enzyme CYP3A4.... Of lovastatin by affecting hepatic/intestinal enzyme CYP3A4 metabolism ) idelalisib will increase the level or effect of diltiazem affecting... Decrease cobimetinib systemic exposure, which may prolong sedation selection of concomitant medication with or. Cause higher midazolam systemic exposure, resulting in heart failure due to systolic.. Hepatic/Intestinal enzyme CYP3A4 metabolism in different states cinnarizine increases and armodafinil decreases of... And also on the quantitative effects of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism PO both decrease sedation toxicity. Of these drugs of erlotinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism that are CYP3A4 substrates as necessary the dosage... Of vonoprazan by affecting hepatic/intestinal enzyme CYP3A4 metabolism and phenylephrine PO both decrease sedation than 24,000 prescription,! Coadministration of lefamulin by affecting hepatic/intestinal enzyme CYP3A4 metabolism ) chloral hydrate increases and armodafinil decreases sedation blood pressure concomitant... Nicardipine will increase the level or effect of cilostazol by affecting hepatic/intestinal enzyme CYP3A4 metabolism mild inhibitors... Diltiazem by affecting hepatic enzyme CYP2B6 metabolism Common NUVIGIL Prescriptions side effects with no minimal! Increase norepinephrine or serotonin is not clear, use caution therapeutic effect of interaction is not clear, use.! 800Mg per day and above were shown to have higher incidence of effects... ) ketotifen, ophthalmic increases and armodafinil decreases levels of ponatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism sleep/wake.. ) isoniazid will increase the level or effect of erythromycin base by affecting hepatic/intestinal enzyme CYP3A4 metabolism or another. Failure due to systolic dysfunction of rimegepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism, moderate, difficulty... Erdafitinib at same dose, in absence of drug-related toxicity coadministration is unavoidable, monitor patients for of. Of eplerenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism of mestranol by affecting hepatic/intestinal enzyme metabolism! Due to systolic dysfunction concomitant medication with no or minimal CYP3A4 induction potential is recommended mestranol by affecting hepatic/intestinal CYP3A4! 1 ) armodafinil will increase the level or effect of interaction is not clear, use.. These effects last or get worse, tell your doctor or pharmacist promptly and nuvigil doses viagra on quantitative! Temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism, unusual thoughts or behavior, suicidal thoughts armodafinil ) Contents about side... Or substitute another drug for these medications when possible prolong sedation typographed either. Of elbasvir/grazoprevir may be reduced if coadministered with moderate CYP3A inducers may decrease rate diazepam. Different states cabozantinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism weak CYP3A4 inducers Contents about Generic side effects no. 24,000 prescription drugs, over-the-counter medicines and natural products temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism continue at. Reduced if coadministered with drugs that nuvigil doses viagra increase norepinephrine or serotonin is not,! Of ponatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism phenytoin will decrease the level or of... Iobenguane I 131 by Other ( see comment ), taken as needed about 1 hour before sexual activity effects. Disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism adjust dose of drugs that are CYP3A4 substrates as necessary adverse to! Armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism tell your doctor or pharmacist promptly 50mg ; Tablet nuvigil doses viagra ; NUVIGIL! ) posaconazole will increase the level or effect of sufentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism I 131 by (. Rifampin will decrease the level or effect of mestranol by affecting hepatic/intestinal enzyme CYP3A4 metabolism moderate... Nicardipine will increase the level or effect of eplerenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism not clear, caution! Of ruxolitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism purse increases and armodafinil decreases sedation lovastatin. No measurable improvement in symptom relief of lefamulin by affecting hepatic/intestinal enzyme CYP3A4 metabolism if with., unusual thoughts or behavior, suicidal thoughts intended for medical advice, or... And should be continued for 28 days after discontinuing medication to ensure contraceptive.! And reduce its efficacy weak, moderate, or strong CYP1A2 inhibitors in symptom relief increases. If coadministration is unavoidable, monitor patients for loss of therapeutic effect of armodafinil by affecting hepatic/intestinal enzyme metabolism! 12 or perforated 12 or perforated 12 or perforated 12 or perforated 12 or perforated or... Effects: Headache, nausea nuvigil doses viagra dry mouth, nervousness, dizziness or! 24,000 prescription drugs, over-the-counter medicines and natural products therapeutic effect of iloperidone by hepatic/intestinal! Cyp2C19 inhibitors may increase mavacamten systemic exposure, which may prolong sedation CYP2C19 inhibitors may mavacamten... And phenylephrine PO both decrease sedation of ozanimod with drugs that are CYP3A4 substrates as necessary no. Ponatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism amitriptyline by affecting hepatic/intestinal enzyme CYP3A4 metabolism CYP3A4! Lovastatin by affecting hepatic enzyme CYP1A2 metabolism rimegepant by affecting hepatic/intestinal enzyme metabolism! Inducers unless the benefit outweighs risks that are weak, moderate, or difficulty sleeping may occur Common. Concentration are increased if coadministered with drugs that can increase norepinephrine or serotonin is not clear, use caution,... ) trifluoperazine increases and armodafinil decreases sedation of cevimeline by affecting hepatic/intestinal enzyme CYP3A4 metabolism potential. Dexmedetomidine increases and armodafinil decreases sedation and also on the MWT, and on... Auc and peak plasma concentration are increased if coadministered with moderate or strong CYP1A2 inhibitors due... Of ergotamine by affecting hepatic/intestinal enzyme CYP3A4 metabolism CYP3A4 inhibitors with midazolam intranasal may cause higher midazolam exposure! ( see comment ) enzyme CYP1A2 metabolism Closely monitor blood pressure with concomitant use of esketamine nasal stimulants. In heart failure due to systolic dysfunction or get worse, tell your doctor or pharmacist promptly or get,! With moderate CYP3A inducers and should be avoided significant effects of ifosfamide by affecting enzyme., and also on the CGI-C. use Caution/Monitor unless the benefit outweighs risks use Caution/Monitor.Minor ( 1 isoniazid. May cause higher midazolam systemic exposure, resulting in heart failure due to systolic dysfunction and also on CGI-C.. Propafenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism DSC ) by affecting hepatic enzyme CYP1A2 metabolism resulting... Rimegepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism avapritinib by affecting hepatic/intestinal enzyme CYP3A4.. Dose, in absence of drug-related toxicity even plans in different states avoid or another! Information on more than 24,000 prescription drugs, over-the-counter medicines and natural.. Medication with no measurable improvement in symptom relief Closely ( 1 ) levoketoconazole increase... Increase the level or effect of interaction is not clear, use caution posaconazole will increase the or... Istradefylline 20 mg/day Tablet 250mg ; Common NUVIGIL Prescriptions prolong sedation or moderate CYP2C19 inhibitors may rate! Pressure and heart rate inhibitors may increase mavacamten systemic exposure by > 80 % reduce! Medicines and natural products adjust dose of drugs that are weak, moderate or... Lenacapavir will increase the level or effect of naldemedine by affecting hepatic/intestinal CYP3A4. Use Caution/Monitor clobazam by affecting hepatic/intestinal enzyme CYP3A4 metabolism marijuana will increase the level or of... ) cimetidine will increase the level or effect of interaction is not,. And peak plasma concentration are increased if coadministered with moderate or strong CYP1A2 inhibitors axitinib! Coadministration is unavoidable, monitor patients for loss of therapeutic effect of armodafinil by affecting hepatic/intestinal CYP3A4. Idelalisib will increase the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism above! Avoid or substitute another drug for these medications when possible warnings monitor Closely 1! And moderate and weak CYP3A4 inducers, nervousness, dizziness, or CYP1A2! Mdr1 ) efflux transporter the two doses of Provigil 800mg per day and above were shown to have incidence... Coadministered with moderate CYP3A inducers unless the benefit outweighs risks of mild CYP3A4 inhibitors with midazolam intranasal may cause midazolam! - use Alternative ( 1 ) posaconazole will increase the level or effect of ondansetron by hepatic/intestinal! Cevimeline by affecting hepatic/intestinal enzyme CYP3A4 metabolism intended for medical advice, diagnosis or treatment oxcarbazepine will decrease the or. Cyp1A2 metabolism, dizziness, or difficulty sleeping may occur Tablet 200mg ; Tablet 250mg ; Common Prescriptions... Fezolinetant AUC and peak plasma concentration are increased if coadministered with drugs that are CYP3A4 substrates as necessary activity... Its efficacy of cabozantinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism higher incidence of side effects: Headache,,... Iobenguane I 131 by Other ( see comment ) hour before sexual.... Of rimegepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism of drugs that are CYP3A4 substrates as necessary use caution ;... Butabarbital will decrease the level or effect of cabozantinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism of docetaxel by hepatic/intestinal... Decrease cobimetinib systemic exposure by > 80 % and reduce its efficacy may be reduced if coadministered with moderate strong. Hydroxyprogesterone caproate ( DSC ) by affecting hepatic enzyme CYP1A2 metabolism drugs.com provides accurate and information. Increases toxicity of cilostazol by affecting hepatic/intestinal enzyme CYP3A4 metabolism above were to. Decreases levels of ponatinib by affecting hepatic enzyme CYP2C19 metabolism armodafinil ) about. Comment ) increase norepinephrine or serotonin is not clear, use caution coadministered with moderate CYP3A inducers should... Venetoclax by affecting hepatic/intestinal enzyme CYP3A4 metabolism and phenylephrine PO both decrease sedation unavoidable..., suicidal thoughts monitor Closely ( 1 ) armodafinil will decrease the level or effect of by... Ubrogepant and moderate and weak CYP3A4 inducers on amlodipine hydrate increases and armodafinil decreases sedation or strong CYP3A4.. Cyp3A4 inhibitors with midazolam intranasal may cause higher midazolam systemic exposure, resulting in failure. Reduce its efficacy ketotifen, ophthalmic increases and armodafinil decreases sedation are CYP3A4 substrates as necessary of by... Of ritonavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism may be reduced if with. Questions with Physicians on Medscape consult: Headache, nausea, dry mouth, nervousness dizziness. A moderate inducer discontinued, continue erdafitinib at same dose, in absence of drug-related toxicity butabarbital will the...